Target Price | CHF219.72 |
Price | CHF212.50 |
Potential | 3.40% |
Number of Estimates | 18 |
18 Analysts have issued a price target Kühne + Nagel International 2026 . The average Kühne + Nagel International target price is CHF219.72. This is 3.40% higher than the current stock price. The highest price target is CHF290.00 36.47% , the lowest is CHF178.00 16.24% . | |
A rating was issued by 20 analysts: 4 Analysts recommend Kühne + Nagel International to buy, 9 to hold and 7 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Kühne + Nagel International stock has an average upside potential 2026 of 3.40% . Most analysts recommend the Kühne + Nagel International stock at Hold. |
12 Analysts have issued a sales forecast Kühne + Nagel International 2025 . The average Kühne + Nagel International sales estimate is CHF24.8b . This is 0.21% lower than the revenue of the last 12 months(TTM). The highest sales forecast is CHF27.5b 10.73% , the lowest is CHF21.9b 11.78% .
This results in the following potential growth metrics:
2024 | CHF24.8b | 4.00% |
---|---|---|
2025 | CHF24.8b | 0.21% |
2026 | CHF25.4b | 2.71% |
2027 | CHF26.4b | 3.67% |
2028 | CHF27.6b | 4.88% |
2029 | CHF30.2b | 9.41% |
15 Analysts have issued an Kühne + Nagel International EBITDA forecast 2025. The average Kühne + Nagel International EBITDA estimate is CHF2.5b . This is 2.47% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is CHF2.8b 12.03% , the lowest is CHF2.1b 14.23% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | CHF2.5b | 6.05% |
---|---|---|
2025 | CHF2.5b | 2.35% |
2026 | CHF2.6b | 4.53% |
2027 | CHF2.8b | 5.44% |
2028 | CHF3.1b | 10.01% |
2029 | CHF3.5b | 15.60% |
2024 | 9.95% | 9.66% |
---|---|---|
2025 | 10.21% | 2.56% |
2026 | 10.39% | 1.76% |
2027 | 10.57% | 1.73% |
2028 | 11.08% | 4.82% |
2029 | 11.71% | 5.69% |
9 Kühne + Nagel International Analysts have issued a net profit forecast 2025. The average Kühne + Nagel International net profit estimate is CHF1.2b . This is 2.19% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is CHF1.3b 11.85% , the lowest is CHF940m 20.64% .
This results in the following potential growth metrics and future Net Margins:
2024 | CHF1.2b | 17.33% |
---|---|---|
2025 | CHF1.2b | 2.09% |
2026 | CHF1.2b | 3.56% |
2027 | CHF1.3b | 5.75% |
2028 | CHF1.4b | 8.86% |
2024 | 4.77% | 20.51% |
---|---|---|
2025 | 4.68% | 1.94% |
2026 | 4.72% | 0.85% |
2027 | 4.82% | 2.12% |
2028 | 5.00% | 3.73% |
9 Analysts have issued a Kühne + Nagel International forecast for earnings per share. The average Kühne + Nagel International EPS is CHF9.76 . This is 2.20% lower than earnings per share in the financial year 2024. The highest EPS forecast is CHF11.16 11.82% , the lowest is CHF7.92 20.64% .
This results in the following potential growth metrics and future valuations:
2024 | CHF9.97 | 17.33% |
---|---|---|
2025 | CHF9.76 | 2.11% |
2026 | CHF10.11 | 3.59% |
2027 | CHF10.69 | 5.74% |
2028 | CHF11.64 | 8.89% |
Current | 21.29 | 6.82% |
---|---|---|
2025 | 21.77 | 2.25% |
2026 | 21.02 | 3.45% |
2027 | 19.88 | 5.42% |
2028 | 18.26 | 8.15% |
Based on analysts' sales estimates for 2025, the Kühne + Nagel International stock is valued at an EV/Sales of 1.07 and an P/S ratio of 1.02 .
This results in the following potential growth metrics and future valuations:
Current | 1.07 | 10.08% |
---|---|---|
2025 | 1.07 | 0.21% |
2026 | 1.04 | 2.64% |
2027 | 1.00 | 3.54% |
2028 | 0.96 | 4.66% |
2029 | 0.87 | 8.60% |
Current | 1.02 | 14.84% |
---|---|---|
2025 | 1.02 | 0.21% |
2026 | 0.99 | 2.64% |
2027 | 0.96 | 3.55% |
2028 | 0.91 | 4.66% |
2029 | 0.83 | 8.60% |
Kühne + Nagel International...
Analyst | Rating | Action | Date |
---|---|---|---|
TD COWEN |
Hold
➜
Hold
|
Unchanged | Jan 05 2025 |
HSBC |
Hold
➜
Hold
|
Unchanged | Nov 24 2024 |
BNP PARIBAS EXANE |
Underperform
➜
Underperform
|
Unchanged | Nov 18 2024 |
STIFEL EUROPE |
Hold
➜
Hold
|
Unchanged | Oct 22 2024 |
RESEARCH PARTNERS AG |
Sell
➜
Sell
|
Unchanged | Oct 03 2024 |
Analyst Rating | Date |
---|---|
Unchanged
TD COWEN:
Hold
➜
Hold
|
Jan 05 2025 |
Unchanged
HSBC:
Hold
➜
Hold
|
Nov 24 2024 |
Unchanged
BNP PARIBAS EXANE:
Underperform
➜
Underperform
|
Nov 18 2024 |
Unchanged
STIFEL EUROPE:
Hold
➜
Hold
|
Oct 22 2024 |
Unchanged
RESEARCH PARTNERS AG:
Sell
➜
Sell
|
Oct 03 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.